CannaTech
JANUARY 3, 2019
Hola 2019! Here’s to 365 days to plant new seeds and harvest what has been planted years prior. In regards to the cannabis plant, Uruguay planted the seeds in Latin America. In December 2013, Uruguay became the first country to legalize cannabis nationwide for medical and non-medical purposes. Now five years later and those seeds have grown throughout the region.
Peninsula Alternative Health
JANUARY 3, 2019
With the passing of the 2018 Farm Bill (also called the Agricultural Improvement Act of 2018), hemp or cannabis sativa has essentially become legal on the federal level, but there are still significant rules and regulations associated with hemp cultivation, processing, and distribution. When it comes to CBD derived from the hemp plant, the rules are a bit difficult to understand, so in this post we will help demystify the farm bill and give an overview of what it means for hemp and its derivativ
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Herb Collective
JANUARY 3, 2019
The first state to legalize marijuana for medical use was California. In 1996, voters passed the Compassionate Use Act, and over the past two decades, it has seen a lot of changes and structure within its cannabis laws. In 2016, voters finally got the Adult Use of Marijuana Act passed for recreational cannabis. California Marijuana rules and regulations have a significant influence on how other states regulate and control cannabis for their medical and recreational sales.
Medicinal Genomics
JANUARY 3, 2019
Medicinal Genomics Corp. (MGC), a pioneer in improving the quality, quantity and safety of cannabis, today announced it has signed a licensing agreement with Eiken Chemical Co., Ltd. of Tokyo, Japan. The licensing agreement covers the use of a dozen patents related to Eiken’s Loop-mediated Isothermal Amplification (LAMP) technology. MGC will integrate the technology in its youPCR™ proprietary cannabis testing platform for the detection of cannabis genes, genotypes, microorganisms, pests a
Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken
The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.
Cannabis Life Network
JANUARY 3, 2019
VANCOUVER, British Columbia, Jan. 03, 2019 (GLOBE NEWSWIRE) — Wildflower Brands Inc. (CSE: SUN) (the “Company”) is excited to announce the opening of its first Wildflower by Bridges General store in Lower Manhattan at 770 Broadway. This retail location is in a high-occupancy office tower housing Facebook’s NYC office, as well as other established digital media companies […].
Medical Cannabis Brief brings together the best content for patients and advocates from the widest variety of industry thought leaders.
The Blunt Truth
JANUARY 3, 2019
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Welcome also to a new year of Week in Weed; after the many cannabis-related events of 2018 , one can only imagine what will be occupying our attention in 2019… This week, saw the release of a disappointing report on the possibility of cannabis banks in California.
WeedAdvisor
JANUARY 3, 2019
If aspiring Canadian marijuana producers and retailers found the approval and licensing process difficult, they will find that theirs is a walk in the park compared to California’s. If we find some serious mistakes in our legalization framework, all we have to do is look at California to reassure ourselves that it could be worse. If smaller licensed producers and dispensaries feel dwarfed by the influence of larger corporations, just remember that their plight is not as bad as the one faced by t
The Joint Blog
JANUARY 3, 2019
Long-term marijuana use is associated with lower BMI (body mass index) and cardiometabolic risk factors, according to a new study published by the journal Psychosomatic Medicine , and epublished by the National Institute of Health. (Photo: Harvard.edu). The study, titled Associations between cannabis use and cardiometabolic risk factors: A longitudinal study of men , “tested longitudinal associations between cannabis use and cardiometabolic risk factors that underlie the development of c
Cannabis Maven
JANUARY 3, 2019
A Cross-platform Educational Series on Cannabis, Sexual Health, and Philanthropy Launches in Portland for 2019.
Cannabis Cheri
JANUARY 3, 2019
Guest Post by Lanny Swerdlow, RN, LNC. Non-steroidal anti-inflammatory drugs (NSAIDs) are used daily by over 17 million Americans to treat headaches, arthritis, sports injuries, menstrual cramps and a litany of other debilitating ailments. The two most commonly used NSAIDs are aspirin and ibuprofen with such familiar brand names as Bayer, Motrin, Excedrin and Advil.
Cannabis Maven
JANUARY 3, 2019
How physicians are playing a crucial role in holistic treatment.
Cannabis Cheri
JANUARY 3, 2019
Guest Post by Lanny Swerdlow, RN, LNC. Pin This! Non-steroidal anti-inflammatory drugs (NSAIDs) are used daily by over 17 million Americans to treat headaches, arthritis, sports injuries, menstrual cramps and a litany of other debilitating ailments. The two most commonly used NSAIDs are aspirin and ibuprofen with such familiar brand names as Bayer, Motrin, Excedrin and Advil.
Cannabis Maven
JANUARY 3, 2019
Elixinol Welcomes Hemp Industry Advocate Joy Beckerman As Regulatory Officer & Industry Liaison.
Expert insights. Personalized for you.
94 
Let's personalize your content